Daily Archives: April 29, 2019

Summer News from MDRI

SUMMER GREETINGS! We thought we’d reach out to you to wish you an enjoyable summer! Here are some updates regarding some of the skin conditions we help treat: Psoriasis Risankizumab (an IL-23 inhibitor) has received FDA approval for the treatment of moderate-to-severe plaque psoriasis. We are proud to have been […]